Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 53
Filter
2.
Epilepsia ; 42(8): 1002-6, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11554885

ABSTRACT

PURPOSE: Treatment with sodium valproate (VPA) may be associated with polycystic ovarian syndrome (PCOS) in some women with epilepsy. By comparing hormone profiles in young adults taking VPA or lamotrigine (LTG) as monotherapy, this study aimed to explore whether a pharmacologic effect of VPA could be responsible for this observation. METHODS: Hormone profiles in men and women taking VPA (n = 40) or LTG (n = 36) monotherapy for epilepsy were compared. None of the women were receiving hormonal contraception or replacement. Patients gave details of seizure type and frequency, menstrual cycle, and medical and drug history. Body mass index was calculated, and fasting insulin, glucose, cholesterol, triglycerides (TG), high- and low-density lipoproteins, testosterone, dihydroepiandosterone (DHEA), androstenedione, sex hormone-binding globulin (SHBG), free androgen index (FAI), luteinising hormone (LH), follicle-stimulating hormone (FSH), and antiepileptic drug (AED) concentrations were measured. RESULTS: There were no differences between treatment groups for both sexes in age and seizure control. Only four obese VPA-treated women were hyperinsulinaemic (p = 0.05); three with abnormal menstrual cycles; one with raised testosterone. Testosterone (p = 0.02), FAI (p = 0.03), and TG (p = 0.02) levels were higher, however, in women taking the drug. Obese patients of both sexes (p = 0.01) and VPA-treated men (p = 0.03) had higher insulin concentrations. CONCLUSIONS: VPA therapy may be associated with subclinical elevation in fasting insulin levels. Testosterone and TG levels were higher in VPA-treated women compared with the levels in those taking LTG. However, only a minority of obese females exhibited biochemical characteristics suggestive of PCOS. Biochemical screening may allow women at risk of developing PCOS to avoid VPA.


Subject(s)
Anticonvulsants/standards , Anticonvulsants/therapeutic use , Epilepsy/blood , Epilepsy/drug therapy , Insulin/blood , Polycystic Ovary Syndrome/chemically induced , Testosterone/blood , Triazines/therapeutic use , Valproic Acid/therapeutic use , Adult , Blood Glucose/analysis , Body Mass Index , Comorbidity , Dehydroepiandrosterone/blood , Epilepsy/epidemiology , Female , Humans , Hyperinsulinism/blood , Hyperinsulinism/epidemiology , Lamotrigine , Lipids/blood , Male , Menstruation Disturbances/blood , Menstruation Disturbances/epidemiology , Obesity/blood , Obesity/epidemiology , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/epidemiology , Sex Factors , Triazines/adverse effects , Triglycerides/blood , Valproic Acid/adverse effects
4.
Clin Chem Lab Med ; 39(12): 1287-90, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11798092

ABSTRACT

This article considers the 18 century European Enlightenment as an example of the cross-fertilization between philosophy propounding rationalist-empirical approach, and arts. The example of Sir Henry Raeburn, a Scottish portraitist, is given to illustrate the influence of the concepts of perception developed by Thomas Reid, the founder of the Scottish school of common sense philosophy, on the style of painting.


Subject(s)
Paintings/history , Philosophy/history , History, 17th Century , History, 18th Century , Perception , Scotland
5.
Clin Chem Lab Med ; 39(10): 907-19, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11758603

ABSTRACT

Risk stratification is a key element of clinical management not only in the primary and secondary prevention, but also during the acute stages of cardiovascular disease. The current risk assessment algorithms in primary prevention are based on established risk factors: gender and age, cigarette smoking, the presence of hypertension and diabetes mellitus, and serum concentrations of total cholesterol, low-density lipoprotein (LDL)-cholesterol and high-density lipoprotein-cholesterol. However, many individuals who are assessed as "low risk" on the basis of traditional risk factors, still develop cardiac events. This article addresses current issues relevant to the assessment of cardiovascular risk. It emphasizes the potential importance of disturbed energy supply for atherogenesis, by introducing the concept of fuel transport (chylomicron, VLDL, and remnants) and overflow (LDL) pathways of lipid metabolism. It highlights the present lack of routine methods to monitor the fuel transport pathway. It considers the measurements of serum C-reactive protein and plasma fibrinogen as new additions to the cardiovascular risk factor profiles. Finally, risk stratification based on the traditional and the new risk factors is linked to that based on the markers of acute myocardial damage such as cardiac troponin I or troponin T. It is concluded that the combined use of the markers of myocardial damage and the "new" cardiovascular risk factors is the way ahead for the assessment of cardiovascular risk.


Subject(s)
Coronary Disease/etiology , Adult , Algorithms , Arteriosclerosis/etiology , Arteriosclerosis/metabolism , Arteriosclerosis/prevention & control , Biomarkers , Coronary Disease/metabolism , Coronary Disease/prevention & control , Energy Metabolism , Female , Humans , Lipid Metabolism , Male , Models, Cardiovascular , National Health Programs , Risk Factors , United States
6.
Clin Chem Lab Med ; 39(10): 997-1000, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11758618

ABSTRACT

There are multiple interrelationships between science, medicine and visual arts. This article discusses aspects of architecture associated with the Greek healing cult of Asklepios, the case in point being the Asklepios temple on the island of Kos in the Aegean. Further, the cult is contrasted with the beginnings of the observation-based medicine practised by Hippocrates (460-c.370 BC). Finally, it is suggested that including elements of visual arts in medical education is consistent with the aims of the new medical curricula.


Subject(s)
History, Ancient , Medicine in the Arts , Education, Medical , Greece, Ancient , Religion and Medicine
7.
Diabetes ; 49(12): 2222-6, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11118030

ABSTRACT

Insulin resistance is of pathogenic importance in several common human disorders including type 2 diabetes, hypertension, obesity and hyperlipidemia, but the underlying mechanisms are unknown. The spontaneously hypertensive rat (SHR) is a model of these human insulin resistance syndromes. Quantitative trait loci (QTLs) for SHR defects in glucose and fatty acid metabolism, hypertriglyceridemia, and hypertension map to a single region on rat chromosome 4. Genetic analysis of an SHR derived from a National Institutes of Health colony led to the identification of a causative mutation in the SHR Cd36. We have investigated glucose and fatty acid metabolism in the stroke-prone SHR (SHRSP). We demonstrate defects in insulin action on 2-deoxy-D-glucose transport (SHRSP 3.3 +/- 1.5 vs. 21.0 +/- 7.4 pmol x min(-1) x [20 microl packed cells](-1), SHRSP vs. WKY, respectively, P = 0.01) and inhibition of catecholamine-stimulated lipolysis (P < 0.05 at all concentrations of insulin) in adipocytes isolated from SHRSP. In contrast, basal levels of catecholamine-stimulated nonesterified free fatty acid (NEFA) release and plasma levels of NEFA are similar in SHRSP and WKY. These results are in agreement with the data on the SHR.4 congenic strain, which suggested that the QTL containing Cd36 mutations accounted for the entire defect in basal catecholamine action but only for approximately 40% of the SHR defect in insulin action. In the SHR, both abnormalities appear consequent of defective Cd36 expression. Because Cd36 sequence and expression are apparently normal in SHRSP, it is likely that the molecular mechanism for defective insulin action in this strain is caused by a gene(s) different than Cd36.


Subject(s)
CD36 Antigens/genetics , Genetic Predisposition to Disease , Insulin Resistance/genetics , Rats, Inbred SHR/genetics , Stroke/genetics , Adipocytes , Animals , Biological Transport , Catecholamines/physiology , Deoxyglucose/pharmacokinetics , Fatty Acids/metabolism , Gene Deletion , Glucose/metabolism , Insulin/physiology , Lipolysis/drug effects , Male , Mutation/genetics , Rats , Rats, Inbred BN , Rats, Inbred WKY
9.
Seizure ; 8(6): 339-42, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10512774

ABSTRACT

This case-controlled study explored the relationship between bone mineral density (BMD) and long-term treatment with antiepileptic drugs (AEDs) in older adults with epilepsy. Seventy-eight patients (47 post-menopausal females, 31 males, aged 47-76 years) with epilepsy participated in the study. Each had only ever received treatment with either enzyme-inducing (n = 52) or non-inducing (n = 26) AEDs. Individuals were matched for age, sex, height and weight with a drug-naive control. All patients underwent bone densitometry at the lumbar spine and femoral neck and had blood sampling and urine collected for a range of bone markers. Male patients had lower BMD than controls at the lumbar spine (P < 0.01) and neck of the femur (P < 0.005). Female patients had significantly reduced bone density at the femoral neck (P < 0.05) only. AED usage was independently associated with an overall reduction in bone density at femoral sites and contributed to just over 5% of the variance at the femoral neck. Duration of treatment and type of AED were not independent factors for reduction in BMD. This case-controlled study supports the hypothesis that long-term AED therapy is an independent risk factor for reduced BMD in epileptic patients. Adults receiving treatment for epilepsy are at higher risk of osteoporosis and should be offered bone densitometry.


Subject(s)
Anticonvulsants/adverse effects , Bone Density/drug effects , Epilepsy/drug therapy , Femur Neck/drug effects , Lumbar Vertebrae/drug effects , Adult , Aged , Case-Control Studies , Epilepsy/blood , Epilepsy/urine , Female , Femur Neck/physiology , Humans , Lumbar Vertebrae/physiology , Male , Middle Aged
10.
Postgrad Med J ; 75(884): 359-60, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10435174

ABSTRACT

Statins are currently the most widely prescribed lipid-lowering drugs. Individual statins are known to be metabolised by the CYP3A4 isoform of the cytochrome P450 system. The effect of CYP3A4 inducers such as phenytoin on the metabolism and efficacy of these agents is unknown. We report a patient with familial hypercholesterolaemia and epilepsy in whom the introduction and subsequent discontinuation of phenytoin were associated with marked changes in the lipid response to treatment with simvastatin and atorvastatin. The serum activity of gamma-glutamyl transpeptidase may have acted as a marker of microsomal induction by phenytoin, since it rose markedly when phenytoin was introduced and returned to normal after it was discontinued.


Subject(s)
Anticholesteremic Agents/therapeutic use , Hyperlipoproteinemia Type II/drug therapy , Phenytoin/therapeutic use , Anticholesteremic Agents/metabolism , Atorvastatin , Cytochrome P-450 Enzyme System/metabolism , Drug Interactions , Epilepsy/drug therapy , Female , Heptanoic Acids/metabolism , Heptanoic Acids/therapeutic use , Humans , Hyperlipoproteinemia Type II/metabolism , Middle Aged , Phenytoin/metabolism , Pyrroles/metabolism , Pyrroles/therapeutic use , Simvastatin/metabolism , Simvastatin/therapeutic use
11.
Clin Chem Lab Med ; 37(2): 97-100, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10219495

ABSTRACT

The essence of the nineties in health care, in business, in organizational management and in education, has been change. As always in a changing environment, there will be winners and losers. In the September issue of CCLM, Williamson wrote: "Poor clinical chemistry. It is a field trapped between pressures from increasing electronic automation of assays, simplified technology and reductionism of molecular genetics and the growing pressure of economic accountability and cost cutting. It may not survive" (1). Should we all be on Prozac and wait for the doomsday? Our problems are not unique. Some time ago, traditional cardiology was "trapped" between the advent of new invasive techniques on the one hand and a pressure to increase emphasis on prevention on the other. How did it end? Most of today's cardiologists are invasive cardiologists and many became leaders in cardiovascular prevention in addition to their "traditional" tasks (2). This is a classical example of a paradigm shift. The present article suggests that at least some of our problems may stem from too narrow a view of laboratory medicine that we present to decision makers who allocate funds to laboratory services.


Subject(s)
Chemistry, Clinical , Laboratories/organization & administration , Algorithms , Management Audit
12.
Cell Mol Biol (Noisy-le-grand) ; 44(7): 1061-8, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9846888

ABSTRACT

Advanced glycation endproducts (AGE) form as a result of non-enzymatic reaction of reducing sugars with proteins. Patients with chronic renal failure (CRF) have elevated AGE in plasma, skin and peritoneum. We measured AGE in the skin and peritoneum of individuals with CRF, patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and in renal transplant recipients (TR). Pentosidine concentration and collagen-linked fluorescence (CLF) were measured. Pentosidine and CLF correlated in all patient groups (CRF r=0.688, p<0.01; CAPD r=0.674, p<0.05; TR r=0.811, p<0.01). Successful kidney transplant reduced AGE levels in the skin (CRF 11.7 +/- 4.51 U/mg; TR 5.02 +/- 3.13 U/mg, p<0.00001) and peritoneum (CRF 17.5 +/- 6.16 U/mg, TR 9.4 +/- 4.97 U/mg, p<0.0001). However in contrast to the TR group, CLF in peritoneum increased following CAPD (CRF 17.5 +/- 6.16 U/mg; CAPD 24.2 +/- 10.4 U/mg; p=0.06). Our results suggest that AGE might be formed in the peritoneum during CAPD treatment.


Subject(s)
Aging/physiology , Glycation End Products, Advanced/metabolism , Kidney Failure, Chronic/metabolism , Kidney Transplantation , Peritoneal Dialysis, Continuous Ambulatory , Peritoneum/metabolism , Skin/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Arginine/analogs & derivatives , Arginine/metabolism , Collagen/metabolism , Humans , Kidney Failure, Chronic/therapy , Lysine/analogs & derivatives , Lysine/metabolism , Middle Aged , Spectrometry, Fluorescence
13.
Cell Mol Biol (Noisy-le-grand) ; 44(7): 1069-79, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9846889

ABSTRACT

Advanced glycation endproducts (AGEs) have been implicated in the pathophysiology of coronary heart disease in ageing, diabetes and renal disease. Competitive enzyme-linked immunosorbent assays (ELISAs) have been developed to measure these compounds in serum, but as recognition of AGEs is both carrier protein- and antibody-dependent standardisation is problematic. We report here on another barrier to standardization, as yet unrecognised. During the development of an AGE ELISA, we found that serum samples did not dilute in parallel to AGE standards or each other. This finding was confirmed by recovery studies that showed over-recovery of AGEs at high serum concentrations, but under-recovery at high dilutions of serum in assay buffer. We developed an inhibition assay to detect factors in serum capable of interacting directly with AGEs immobilised on microtitre plates. Binding of these factors prevented recognition of AGEs by a CML monoclonal antibody and a polyclonal anti-AGE antibody, and was neither sugar- nor carrier protein-dependent. We detected the presence of this factor in all human sera tested and also in foetal calf serum. Pre-incubation of sera with AGEs or heat-treatment at 56 degrees C for 30 min. significantly reduced this binding. We are currently investigating the nature of this factor and the possibility that it may be complement. The effect of this factor on immunoassays for AGEs can only be detected by performing parallelism and recovery studies and we suggest the use of the method referred to in this paper to aid interpretation of parallelism data.


Subject(s)
Blood Physiological Phenomena , Enzyme-Linked Immunosorbent Assay/methods , Glycation End Products, Advanced/blood , Antibodies/immunology , Antibodies, Monoclonal/immunology , Glycation End Products, Advanced/immunology , Glycation End Products, Advanced/metabolism , Hot Temperature , Humans , Lysine/analogs & derivatives , Lysine/immunology , Lysine/metabolism , Reference Standards
14.
Diabet Med ; 15(11): 920-3, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9827845

ABSTRACT

The Diabetes Control and Complications Trial (DCCT) has provided objective evidence for desirable glycaemic control in Type 1 patients and defines the benefits of good glycaemic control in terms of haemoglobin A1c (HbA1c) values. However, HbA1c assays vary, leading to suggestions that glycaemic control be classified according to numbers of standard deviations (SD) from a local non-diabetic population mean. We have classified the glycaemic control of 339 UK Type 1 diabetic patients (182 male, 157 female, median age 36 (range 15-74) years) using the DCCT to set HbA1c targets and compared this with the SD method. Using age matched controls (mean HbA1c 4.02%, SD 0.28%, n=106), SD guidelines classified 1% of patients into good (HbA1c <3SD from reference mean), 4% into borderline (3-5SD) and 95% into poor (>5SD) glycaemic control. When calibrating the same instrument to the DCCT analyser (r=0.996), 37% of patients had HbA1c results lower than the 7% median value found in the intensively treated DCCT group, while only 12% of patients had values greater than the 9% conventionally treated median HbA1c. DCCT subjects with HbA1c values of less than 8% belonged predominantly to the intensively treated group. In this study, 71% of patients fell into this category. Thus, guidelines based on numbers of SD away from a non-diabetic mean may overestimate the glycaemic control required to reduce microvascular complications in Type 1 patients. Standardizing to DCCT targets is more appropriate.


Subject(s)
Biomarkers/blood , Blood Glucose/metabolism , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/therapy , Glycated Hemoglobin/metabolism , Adolescent , Adult , Aged , Europe , Female , Glycated Hemoglobin/analysis , Humans , Male , Middle Aged , Practice Guidelines as Topic , United Kingdom
15.
J Med Genet ; 35(7): 573-8, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9678702

ABSTRACT

Familial hypercholesterolaemia (FH) is an autosomal codominant disorder characterised by high levels of LDL cholesterol and a high incidence of coronary artery disease. Our aims were to track the low density lipoprotein receptor (LDLR) gene in individual families with phenotypic FH and to identify and characterise any mutations of the LDLR gene that may be common in the west of Scotland FH population using single strand conformational polymorphism analysis (SSCP). Patient samples consisted of 80 heterozygous probands with FH, 200 subjects who were related to the probands, and a further 50 normal, unrelated control subjects. Tracking of the LDLR gene was accomplished by amplification of a 19 allele tetranucleotide microsatellite that is tightly linked to the LDLR gene locus. Primers specific for exon 4 of the LDLR gene were used to amplify genomic DNA and used for SSCP analysis. Any PCR products with different migration patterns as assessed by SSCP were then sequenced directly. In addition to identifying probands with a common mutation, family members were screened using a forced restriction site assay and analysed using microplate array diagonal gel electrophoresis (MADGE). Microsatellite D19S394 analysis was informative in 20 of 23 families studied. In these families there was no inconsistency with segregation of the FH phenotype with the LDLR locus. Of the FH probands, 15/80 had a mutant allele as assessed by SSCP using three pairs of primers covering the whole of exon 4 of the LDLR gene. Direct DNA sequencing showed that 7/15 of the probands had a C163Y mutation. Using a PCR induced restriction site assay for the enzyme RsaI and MADGE, it was determined that the C163Y mutation cosegregated with the FH phenotype in family members of the FH probands. This mutant allele was not present in any of the control subjects. Microsatellite analysis has proven useful in tracking the LDLR gene and could be used in conjunction with LDL cholesterol levels to diagnose FH, especially in children and young adults where phenotypic diagnosis can be difficult.


Subject(s)
Hyperlipoproteinemia Type II/genetics , Point Mutation , Receptors, LDL/genetics , Adult , Base Sequence , Child , DNA Primers/genetics , Female , Founder Effect , Genetic Linkage , Genetic Testing , Humans , Hyperlipoproteinemia Type II/diagnosis , Hyperlipoproteinemia Type II/metabolism , Male , Microsatellite Repeats , Pedigree , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational , Scotland
16.
Clin Chem Lab Med ; 36(3): 133-6, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9589799

ABSTRACT

Educational activities are a background to research and to a dynamic, developing discipline. The principles now being applied in undergraduate curricula are applicable to teaching and training in laboratory medicine. A fresh look at the education and training and an implementation of new educational techniques is necessary to prepare a cadre of individuals who will be developing laboratory medicine in the 21st century.


Subject(s)
Chemistry, Clinical/education , Education, Medical, Undergraduate/trends , Medical Laboratory Personnel/education , Clinical Laboratory Techniques/trends , Curriculum , Humans , International Cooperation
18.
Circulation ; 96(2): 556-61, 1997 Jul 15.
Article in English | MEDLINE | ID: mdl-9244225

ABSTRACT

BACKGROUND: Increased activity of the sympathetic nervous system has been proposed as a cause of high blood pressure (BP) and may be related to diet and body weight. To determine the role of these factors in predisposition to high BP, we studied 100 young adults with high or low BP from families in which both parents had either high or low BP. METHODS AND RESULTS: Plasma catecholamine, glucose, and insulin levels were measured before and after an oral glucose load. There was a significant correlation between fasting plasma norepinephrine and mean arterial pressure (P=.001). Subjects with high BP, irrespective of parental BP, were heavier (P=.003) and fatter (P=.002) and had a greater rise in plasma insulin (P=.003) following glucose than those with low BP. Offspring with high BP whose parents also had high BP showed an unexpected rise in plasma epinephrine (P=.004) following glucose. This adrenal medullary response was not the result of high parental or high personal BP alone as it was not seen in offspring with low BP whose parents had high BP or in offspring with high BP whose parents had low BP. CONCLUSIONS: Irrespective of family history, high BP is associated with increased body weight and hyperinsulinemia and reflects personal environment and behavior. However, abnormal epinephrine release is characteristic of the combination of genetic, environmental, and behavioral factors that is associated with high personal BP and a familial predisposition to high BP.


Subject(s)
Blood Pressure , Norepinephrine/blood , Adolescent , Adult , Blood Glucose , Blood Pressure/genetics , Female , Humans , Insulin/blood , Male
19.
Clin Chim Acta ; 263(2): 239-47, 1997 Jul 25.
Article in English | MEDLINE | ID: mdl-9246427

ABSTRACT

Nonenzymatic glycation of proteins and oxidative stress are considered independent factors important in the development of the complications of diabetes but may be interrelated by the process of autoxidative glycation. This pathway involves monosaccharide autoxidation to a reactive ketoaldehyde analogue and subsequent reaction with protein to form a ketoimine adduct. This study demonstrates that delta-gluconolactone (delta-GL), an oxidised analogue of glucose, is a potent glycating agent in vitro of haemoglobin present in blood samples from insulin-dependent diabetic and non-diabetic human subjects and from spontaneously diabetic, insulin-dependent BB/Edinburgh (BB/E) rats. The percentage glycated haemoglobin after incubation (37 degrees C, 5 h) with delta-GL (25 mmol/l) was significantly (P < 0.002) higher than that observed using an equimolar concentration of glucose. Intravenous administration of delta-GL (1 g/kg) to non-diabetic BB/E rats also significantly increased glycation of haemoglobin (6.0 +/- 0.1% vs 4.9 +/- 0.1%, P < 0.01) whereas intravenous injection of an identical dose of glucose had no significant effect (5.1 +/- 0.1% vs 5.0 +/- 0.2%). These results support the hypothesis that nonenzymatic glycation of proteins involves attachment by both native and oxidised monosaccharides. Further investigation of the interactions between diabetes-associated increases in oxidative stress and glycation on the development and progression of the vascular complications of diabetes is necessary.


Subject(s)
Gluconates/pharmacology , Glycated Hemoglobin/drug effects , Glycated Hemoglobin/metabolism , Hemoglobins/drug effects , Hemoglobins/metabolism , Animals , Diabetes Mellitus, Type 1/blood , Diabetic Angiopathies/blood , Diabetic Angiopathies/etiology , Glycosylation , Humans , In Vitro Techniques , Kinetics , Lactones , Oxidation-Reduction , Oxidative Stress , Rats , Rats, Inbred BB
20.
Clin Sci (Lond) ; 92(3): 237-46, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9093003

ABSTRACT

1. We measured sodium-lithium countertransport, sodium-hydrogen exchange and membrane micro-viscosity in 48 individuals with familial hypercholesterolaemia, 33 subjects with hypertriglyceridaemia and 54 normolipaemic controls. Full lipid profile, blood pressure, body mass index, fasting glucose and insulin levels were also measured. 2. Subjects with hypertriglyceridaemia had higher blood pressure, body mass index, fasting glucose and insulin levels than normal controls. 3. Vmax of the sodium-lithium countertransport was elevated in the hypertriglyceridaemic group compared with controls. Across the whole group log(e) triacylglycerols correlated with Vmax of the sodium-lithium countertransport. There was no difference in sodium-lithium countertransport K(m) between the groups. 4. Sodium-hydrogen maximal proton efflux rate (Vmax) and K(m) were not different between the three groups. There were no correlations between sodium-hydrogen exchange and sodium-lithium countertransport parameters. 5. Microviscosity as measured by diphenylhexatriene was reduced at the core of the membrane in subjects with hypertriglyceridaemia compared with those with familial hypercholesterolaemia or normolipaemic controls, suggesting an alteration in membrane structure. 6. Changes in sodium transport in hyperlipidaemia may be mediated by changes in membrane structure resulting in altered protein conformation or turnover.


Subject(s)
Antiporters/metabolism , Hyperlipidemias/metabolism , Lithium/metabolism , Sodium-Hydrogen Exchangers/metabolism , Sodium/metabolism , Biological Transport, Active , Erythrocyte Membrane/metabolism , Female , Humans , Hyperlipoproteinemia Type II/metabolism , Hypertriglyceridemia/metabolism , Male , Middle Aged , Viscosity
SELECTION OF CITATIONS
SEARCH DETAIL
...